Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2010
12/01/2010CN101422436B Dry powder composite for suction
12/01/2010CN101396354B Stable taxabe compound liquid combination and preparation method and use thereof
12/01/2010CN101386625B Vinflunine derivates and preparation method thereof and application thereof in preparing medicament for targeted therapy solid tumors, liver cancer or lung cancer
12/01/2010CN101380473B Gold nano-bar based medicine carrier and preparation technique and use thereof
12/01/2010CN101342142B Temperature sensing in situ gel rubber formulations capable of being injected, preparation method and uses thereof
12/01/2010CN101318021B Method for preparing composite vitamin beta-cyclodextrin clathrate compound
12/01/2010CN101314044B Oxidation resistance ligand functionalized golden nano-complexes, preparation method and application thereof
12/01/2010CN101306203B Hydrophilic polymer-boxwood extract conjugate and its medicine composition
12/01/2010CN101292994B Method for relieving or neutralizing the effect of alcohol, and products thereof
12/01/2010CN101259286B Method for constructing liver target drug-carrying polymer micelle
12/01/2010CN101259099B Nano granule preparations of catharanthus roseus alkaloids anti-tumor medicaments and preparation thereof
12/01/2010CN101254201B Diastatin nystatin menthol combination with cooperating knife-bar
12/01/2010CN101254174B Freeze-dried injection containing carbazochrome sodium sulfonate and method of preparing the same
12/01/2010CN101245147B Composition and synthesizing process for biodegradable amphiphilic polyphosphazenes as dewatering medicament nano-preparations carrier
12/01/2010CN101229218B Vanadium compounds for curing diabetes and preparing method thereof
12/01/2010CN101227952B Emulsified skin external preparation and method for stabilizing the skin external preparation
12/01/2010CN101171006B Film coated preparation
12/01/2010CN101161290B Beta-elemi alkene polyglycol amine derivant as well as its synthesis method and purpose
12/01/2010CN101129373B Method for preparing Imiquimod chitosannano granule
12/01/2010CN101125123B Red sage root A magnesium injection preparation and preparation method thereof
12/01/2010CN101112511B Chinese traditional medicine gelling agent for treating laryngopharynx gall
12/01/2010CN101019872B Nanometer antiviral liposome medicine and its preparation
12/01/2010CN101002758B Use of composition for treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
12/01/2010CN100998697B Lozenge made of traditional Chinese medicine for treating throat disease, and its preparing method
12/01/2010CA2667708A1 Hydrogel systems
11/2010
11/30/2010US7842791 Dispersible pharmaceutical compositions
11/30/2010US7842787 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
11/30/2010US7842667 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
11/30/2010US7842313 System and method for applying medication to a hoof
11/30/2010US7842311 for oral dosage; for treatment of pain; sustained release
11/30/2010US7842310 Pharmaceutical compositions in particulate form
11/30/2010US7842309 Tamper-resistant oral opioid agonist formulations
11/30/2010CA2538205C Nucleosides with anti-hepatitis b virus activity
11/30/2010CA2480123C Highly aqueous liquid carrier formulations
11/30/2010CA2473038C Weight management system for obese animals
11/30/2010CA2449352C Nsaid formulation comprising a granular composition and an extra-granular composition
11/30/2010CA2412804C Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
11/30/2010CA2396129C Method and formulation for treating resistance to antihypertensives and related conditions
11/30/2010CA2362932C Pharmaceutical composition containing proton pump inhibitors
11/30/2010CA2326653C Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
11/25/2010WO2010135736A2 Application and uses of prg4 and therapeutic modulation thereof
11/25/2010WO2010135547A1 Antibodies directed to gpnmb and uses thereof
11/25/2010WO2010135527A2 Elastin for soft tissue augmentation
11/25/2010WO2010134942A1 Electrostatically charged multi-acting nasal application, product and method
11/25/2010WO2010134829A2 Nanocapsules intended for transferring toxic drugs to the sites of invasive diseases occurrence in a patient body and method of their preparation
11/25/2010WO2010134614A1 SELF-EMULSIFYING COMPOSITION OF ω3 FATTY ACID
11/25/2010WO2010134574A1 Orally disintegrating tablet
11/25/2010WO2010134568A1 Bitterness-suppressing agent
11/25/2010WO2010134556A1 Aqueous injection solution containing 5-methyl-2-(1-piperazinyl)benzenesulfonic acid derivative
11/25/2010WO2010134540A1 Dry-coated orally-disintegrating tablet
11/25/2010WO2010134433A1 Transdermal preparation
11/25/2010WO2010133941A2 New hybrid particles and their use in diagnostics and therapy
11/25/2010WO2010133609A2 Composition comprising oil drops
11/25/2010WO2010111212A4 Methods of identifying potential components for targeted drug delivery compositions
11/25/2010WO2010108937A3 Drug fusions and conjugates
11/25/2010WO2010095940A3 Glutathione-based drug delivery system
11/25/2010WO2010093523A3 Foamable microemulsion compositions for topical administration
11/25/2010WO2010093452A3 Reducible polymers for non-viral gene delivery
11/25/2010WO2010088185A3 Matte skin finish compositions
11/25/2010WO2010085123A3 Composition applicable to skin and capable of improving blood circulation and enlarging blood vessels
11/25/2010WO2010081800A3 Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
11/25/2010WO2010078538A3 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
11/25/2010WO2010077867A3 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
11/25/2010WO2010048087A3 Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
11/25/2010WO2009148580A3 Controlled release copolymer formulation with improved release kinetics
11/25/2010WO2009142893A3 Methods and compositions for the delivery of bioactive compounds
11/25/2010WO2009136352A8 Anti-angiogenic compounds
11/25/2010WO2009093250A3 Targeting of innate immune response to tumor site
11/25/2010US20100298769 Implantable medical devices for therapeutic agent delivery
11/25/2010US20100298552 Emulsion compositions
11/25/2010US20100298525 Functionalized water-soluble polyphosphazenes and uses thereof as modifiers of biological agents
11/25/2010US20100298496 Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
11/25/2010US20100298447 Composite product of low-solubility drug and surfactant, and process for production thereof
11/25/2010US20100298446 Actinically-crosslinkable siloxane-containing copolymers
11/25/2010US20100298435 Stable Emulsions of Oils in Aqueous Solutions and Methods for Producing Same
11/25/2010US20100298420 Compositions and Methods for Intracellular Delivery
11/25/2010US20100298276 Thyroid receptor ligands
11/25/2010US20100298266 Hydroxyethylstarch
11/25/2010US20100298240 Pmma binding peptides
11/25/2010US20100298231 Pmma binding peptides
11/25/2010US20100297669 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
11/25/2010US20100297263 Colon cleansing compositions and methods
11/25/2010US20100297232 Ondansetron film compositions
11/25/2010US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing
11/25/2010US20100297215 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
11/25/2010US20100297202 Planar antenna and method of manufacturing the same
11/25/2010US20100297155 Phosphazene hydrogels with chemical corss-link, preparation method thereof and use thereof
11/25/2010US20100297082 Weight-bearing polyurethane composites and methods thereof
11/25/2010US20100297069 Pegylated interleukin-10
11/25/2010US20100297047 Esters of glycerol and their uses in cosmetic and pharmaceutical applications
11/25/2010US20100297044 Emulsifier Mixture Containing Fatty Alcohols, Ethoxylated Fatty Alcohols and Oil or Wax Components
11/25/2010US20100297023 Lipid
11/25/2010US20100297009 Self-assembled polyhedral multimeric chemical structures
11/25/2010US20100297006 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
11/25/2010CA2762989A1 Application and uses of prg4 and therapeutic modulation thereof
11/25/2010CA2762939A1 Self-emulsifying composition of .omega.3 fatty acid
11/25/2010CA2762770A1 Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing
11/25/2010CA2762391A1 Liquid dosage forms of isotretinoin
11/25/2010CA2762212A1 Elastin for soft tissue augmentation
11/25/2010CA2762179A1 Composition comprising oil drops
1 ... 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 ... 1712